This company listing is no longer active
Jeisys Medical (A287410) Stock Overview
Designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
A287410 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Jeisys Medical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩12,900.00 |
| 52 Week High | ₩13,800.00 |
| 52 Week Low | ₩7,390.00 |
| Beta | 0.44 |
| 1 Month Change | 0.23% |
| 3 Month Change | -0.31% |
| 1 Year Change | 1.18% |
| 3 Year Change | 96.65% |
| 5 Year Change | n/a |
| Change since IPO | 203.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| A287410 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 0% | 5.0% | -3.6% |
| 1Y | 1.2% | -14.9% | 148.4% |
Return vs Industry: A287410 underperformed the KR Medical Equipment industry which returned 12.3% over the past year.
Return vs Market: A287410 underperformed the KR Market which returned 3.2% over the past year.
Price Volatility
| A287410 volatility | |
|---|---|
| A287410 Average Weekly Movement | 0.8% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 9.3% |
| 10% most volatile stocks in KR Market | 16.5% |
| 10% least volatile stocks in KR Market | 4.9% |
Stable Share Price: A287410 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A287410's weekly volatility has decreased from 7% to 1% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 275 | n/a | www.jeisys.com/2016 |
Jeisys Medical Inc. designs, develops, and manufactures medical device for plastic surgeons, dermatologist, physicians, and healthcare professionals in South Korea and internationally. The company offers products for treatment areas, such as skin rejuvenation, lifting/tightening, pigmentation treatments, fat reduction, acne, tattoo removal, and scars and striae distensae under the ULTRAcel Q+ system, Cellec V system, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel brands. It provides its products through a network of distributors.
Jeisys Medical Inc. Fundamentals Summary
| A287410 fundamental statistics | |
|---|---|
| Market cap | ₩960.86b |
| Earnings (TTM) | ₩27.97b |
| Revenue (TTM) | ₩167.82b |
Is A287410 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A287410 income statement (TTM) | |
|---|---|
| Revenue | ₩167.82b |
| Cost of Revenue | ₩50.80b |
| Gross Profit | ₩117.03b |
| Other Expenses | ₩89.06b |
| Earnings | ₩27.97b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 375.50 |
| Gross Margin | 69.73% |
| Net Profit Margin | 16.67% |
| Debt/Equity Ratio | 60.6% |
How did A287410 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/08 05:18 |
| End of Day Share Price | 2024/10/18 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Jeisys Medical Inc. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sae-rom Lee | Daishin Securities Co. Ltd. |
| Jonghyun Park | DAOL Investment & Securities Co., Ltd. |
| Sangsoo Kim | Goldman Sachs |